• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受棘白菌素长期治疗的患者中发现携带F652S Fks1改变的泛棘白菌素耐药情况。

Pan-Echinocandin Resistant Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy.

作者信息

Siopi Maria, Papadopoulos Antonios, Spiliopoulou Anastasia, Paliogianni Fotini, Abou-Chakra Nissrine, Arendrup Maiken Cavling, Damoulari Christina, Tsioulos Georgios, Giannitsioti Efthymia, Frantzeskaki Frantzeska, Tsangaris Iraklis, Pournaras Spyros, Meletiadis Joseph

机构信息

Clinical Microbiology Laboratory, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

4th Department of Internal Medicine, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

出版信息

J Fungi (Basel). 2022 Sep 1;8(9):931. doi: 10.3390/jof8090931.

DOI:10.3390/jof8090931
PMID:36135656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9502558/
Abstract

The isolation of a pan-echinocandin-resistant Candida parapsilosis strain (anidulafungin, caspofungin, micafungin and rezafungin EUCAST MICs > 8 mg/L) from urine of a patient following prolonged exposure to echinocandins (38 days of micafungin followed by 16 days of anidulafungin) is described. The isolate harbored the novel alteration F652S in the hotspot 1 region of fks1. Isogenic C. parapsilosis bloodstream isolates collected up to 1.5 months earlier from the same patient were susceptible to echinocandins (anidulafungin, caspofungin and micafungin EUCAST MICs 1−2, 1 and 1 mg/L, respectively) and contained wild-type FKS1 sequences. This is the first report of pan-echinocandin resistance in C. parapsilosis associated with an aminoacid change in hotspot 1 region of fks1.

摘要

本文描述了从一名长期接受棘白菌素治疗(先使用米卡芬净38天,后使用阿尼芬净16天)的患者尿液中分离出一株对所有棘白菌素耐药的近平滑念珠菌菌株(阿尼芬净、卡泊芬净、米卡芬净和瑞扎芬净的欧洲抗微生物药敏试验委员会(EUCAST)最低抑菌浓度(MIC)>8 mg/L)。该分离株在fks1热点1区域存在新型突变F652S。在更早之前(最早提前1.5个月)从同一患者收集的近平滑念珠菌血流分离株对棘白菌素敏感(阿尼芬净、卡泊芬净和米卡芬净的EUCAST MIC分别为1−2、1和1 mg/L),且含有野生型FKS1序列。这是首例与fks1热点1区域氨基酸变化相关的近平滑念珠菌对所有棘白菌素耐药的报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/9502558/883ec800a4bf/jof-08-00931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/9502558/883ec800a4bf/jof-08-00931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5056/9502558/883ec800a4bf/jof-08-00931-g001.jpg

相似文献

1
Pan-Echinocandin Resistant Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy.在接受棘白菌素长期治疗的患者中发现携带F652S Fks1改变的泛棘白菌素耐药情况。
J Fungi (Basel). 2022 Sep 1;8(9):931. doi: 10.3390/jof8090931.
2
Decreased echinocandin susceptibility in causing candidemia and emergence of a pan-echinocandin resistant case in China.棘白菌素类药物敏感性降低导致念珠菌血症和中国出现泛棘白菌素耐药病例。
Emerg Microbes Infect. 2023 Dec;12(1):2153086. doi: 10.1080/22221751.2022.2153086.
3
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.在瑞典进行的为期一年的研究中,对收集到的念珠菌分离株进行棘白菌素药敏试验。
J Clin Microbiol. 2011 Jul;49(7):2516-21. doi: 10.1128/JCM.00201-11. Epub 2011 May 4.
4
Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?携带Fks1p热点1区域新突变R658G的与遗传相关的耐米卡芬净近平滑念珠菌血液分离株:一个新挑战?
J Antimicrob Chemother. 2021 Jan 19;76(2):418-422. doi: 10.1093/jac/dkaa419.
5
Rezafungin Activity against Contemporary Nordic Clinical Isolates and Determined by the EUCAST Reference Method.雷沙康唑对北欧临床分离株的活性及 EUCAST 参考方法的测定。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02438-19.
6
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
7
Spontaneous Mutational Frequency and Mutation Rates Vary by Echinocandin Agent against .棘白菌素类药物对. 的自发突变频率和突变率各不相同。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01692-18. Print 2019 Jan.
8
Echinocandin antifungal drugs in fungal infections: a comparison.棘白菌素类抗真菌药物治疗真菌感染:比较。
Drugs. 2011 Jan 1;71(1):11-41. doi: 10.2165/11585270-000000000-00000.
9
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.阿尼芬净、卡泊芬净和米卡芬净对从烧伤病房分离出的近平滑念珠菌菌株的体外活性差异。
Clin Microbiol Infect. 2009 Mar;15(3):274-9. doi: 10.1111/j.1469-0691.2008.02660.x. Epub 2009 Feb 5.
10
Genetic Mutations in FKS1 Gene Associated with Acquired Echinocandin Resistance in Candida parapsilosis Complex.FKS1 基因突变与近平滑念珠菌复合体获得性棘白菌素耐药性相关。
Mycopathologia. 2024 May 5;189(3):40. doi: 10.1007/s11046-024-00847-0.

引用本文的文献

1
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options.生物膜相关性念珠菌病:发病机制、患病率、挑战与治疗选择
Pharmaceuticals (Basel). 2025 Mar 25;18(4):460. doi: 10.3390/ph18040460.
2
Comparative evaluation of antifungal susceptibility testing methods of invasive Candida species and detection of FKS genes mutations in caspofungin intermediate and resistant isolates.侵袭性念珠菌属抗真菌药敏试验方法的比较评估以及卡泊芬净中介和耐药菌株中FKS基因突变的检测
BMC Infect Dis. 2025 Jan 24;25(1):114. doi: 10.1186/s12879-024-10435-8.
3
Threats from the complex: the surge of multidrug resistance and a hotbed for new emerging pathogens.

本文引用的文献

1
ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candidaglabrata.FKS2 基因 HS1 处的 ΔF659 和 F659S 取代,以及上下游的 E655A 和 W715L 取代,与对 Candida glabrata 的高伊曲康唑 MIC 值相关。
Clin Microbiol Infect. 2022 Aug;28(8):1154.e5-1154.e8. doi: 10.1016/j.cmi.2022.04.003. Epub 2022 Apr 12.
2
Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?关于《与遗传相关的对米卡芬净耐药的近平滑念珠菌血液分离株在Fks1p热点1区域存在新突变R658G:一个新挑战?》的评论
J Antimicrob Chemother. 2022 May 29;77(6):1790. doi: 10.1093/jac/dkac091.
3
复杂因素带来的威胁:多重耐药性的激增以及新出现病原体的温床。
Microbiol Mol Biol Rev. 2024 Dec 18;88(4):e0002923. doi: 10.1128/mmbr.00029-23. Epub 2024 Nov 7.
4
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.新型抗真菌药物和治疗方法,以应对耐药性并改善侵袭性真菌感染的治疗结局。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0007423. doi: 10.1128/cmr.00074-23. Epub 2024 Apr 11.
5
Evaluation of outbreak persistence caused by multidrug-resistant and echinocandin-resistant using multidimensional experimental and epidemiological approaches.采用多维实验和流行病学方法评估耐多药和棘白菌素耐药所致暴发的持续性。
Emerg Microbes Infect. 2024 Dec;13(1):2322655. doi: 10.1080/22221751.2024.2322655. Epub 2024 Mar 5.
6
First Canadian report of transmission of fluconazole-resistant within two hospital networks confirmed by genomic analysis.首例通过基因组分析确认的两医院网络内传播的氟康唑耐药 :来自加拿大的报告。
J Clin Microbiol. 2024 Jan 17;62(1):e0116123. doi: 10.1128/jcm.01161-23. Epub 2023 Dec 19.
7
A new PK/PD target for assessing efficacy of micafungin against Candida parapsilosis.评估米卡芬净对近平滑念珠菌疗效的新 PK/PD 靶标。
J Antimicrob Chemother. 2024 Jan 3;79(1):157-165. doi: 10.1093/jac/dkad360.
8
Antifungal Resistance Mechanisms and Associated Epidemiology.抗真菌耐药机制及相关流行病学
J Fungi (Basel). 2023 Jul 28;9(8):798. doi: 10.3390/jof9080798.
9
Fluconazole and echinocandin resistance of species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak.在 COVID-19 大流行之前和期间,大学医院侵袭性念珠菌病中 属的氟康唑和棘白菌素耐药性。
Epidemiol Infect. 2023 Aug 25;151:e146. doi: 10.1017/S0950268823001346.
10
Aneuploidy enables cross-tolerance to unrelated antifungal drugs in .非整倍体使[具体生物]对不相关抗真菌药物产生交叉耐受性。 (你提供的原文“Aneuploidy enables cross-tolerance to unrelated antifungal drugs in.”似乎不完整,这里补充了推测的“[具体生物]”使句子完整表意,你可根据实际情况调整。)
Front Microbiol. 2023 Apr 11;14:1137083. doi: 10.3389/fmicb.2023.1137083. eCollection 2023.
Candidemia among Hospitalized Pediatric Patients Caused by Several Clonal Lineages of .由多种克隆谱系引起的住院儿科患者念珠菌血症
J Fungi (Basel). 2022 Feb 12;8(2):183. doi: 10.3390/jof8020183.
4
Increasing Incidence and Shifting Epidemiology of Candidemia in Greece: Results from the First Nationwide 10-Year Survey.希腊念珠菌血症发病率上升及流行病学变化:首次全国性十年调查结果
J Fungi (Basel). 2022 Jan 26;8(2):116. doi: 10.3390/jof8020116.
5
Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of São Paulo State, Brazil.巴西圣保罗州 22 家医院的念珠菌临床分离株的抗真菌药敏谱。
Braz J Med Biol Res. 2021 Jun 14;54(9):e10928. doi: 10.1590/1414-431X2020e10928. eCollection 2021.
6
Candidemia and Invasive Candidiasis.念珠菌血症和侵袭性念珠菌病。
Infect Dis Clin North Am. 2021 Jun;35(2):389-413. doi: 10.1016/j.idc.2021.03.007.
7
Prevalence and Antifungal Susceptibility of Species Complex in Eastern China: A 15-Year Retrospective Study by ECIFIG.中国东部地区物种复合体的患病率及抗真菌药敏性:ECIFIG进行的一项15年回顾性研究
Front Microbiol. 2021 Mar 4;12:644000. doi: 10.3389/fmicb.2021.644000. eCollection 2021.
8
Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?携带Fks1p热点1区域新突变R658G的与遗传相关的耐米卡芬净近平滑念珠菌血液分离株:一个新挑战?
J Antimicrob Chemother. 2021 Jan 19;76(2):418-422. doi: 10.1093/jac/dkaa419.
9
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens.耐药性侵袭性真菌病原体悄无声息且未得到充分重视的崛起
J Fungi (Basel). 2020 Aug 18;6(3):138. doi: 10.3390/jof6030138.
10
Echinocandin resistance in Candida parapsilosis sensu stricto: Role of alterations in CHS3, FKS1 and Rho gene expression.棘白菌素耐药性在近平滑念珠菌中的研究:CHS3、FKS1 和 Rho 基因表达改变的作用。
J Glob Antimicrob Resist. 2020 Sep;22:685-688. doi: 10.1016/j.jgar.2020.06.025. Epub 2020 Jul 9.